Skip to main content
. 2014 Dec 4;8(12):e3259. doi: 10.1371/journal.pntd.0003259

Figure 1. Anti–Trypanosoma cruzi compounds.

Figure 1

Chemical structures of anti–T. cruzi compounds currently in clinical use (*) and currently or recently in clinical trials (•), and of the most promising compounds retrieved out of the Broad Institute HTS campaign [44] and the screening of a smaller, diversity-oriented chemical library [39], [43] (#).